Invention Grant
- Patent Title: Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
-
Application No.: US13886448Application Date: 2013-05-03
-
Publication No.: US08940778B2Publication Date: 2015-01-27
- Inventor: Yujia Dai , Steven K Davidsen , Anna M. Ericsson , Kresna Hartandi , Zhiqin Ji , Michael R. Michaelides
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Glen J. Gesicki
- Main IPC: C07D291/00
- IPC: C07D291/00 ; C07D409/10 ; C07D409/04 ; C07D401/12 ; C07D261/20 ; C07D409/12 ; C07D403/12 ; C07D409/14 ; C07D275/04 ; C07D401/04 ; C07D401/10 ; C07D413/12 ; C07D403/14 ; C07D231/56
Abstract:
Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Public/Granted literature
- US20130245015A1 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS Public/Granted day:2013-09-19
Information query
